Relationships between body fat accumulation, aerobic capacity and insulin resistance in Japanese participants

Fibro-adipogenic progenitors in physiological adipogenesis and intermuscular adipose tissue remodeling

Excessive accumulation of intermuscular adipose tissue (IMAT) is a common pathological feature in various metabolic and health conditions and can cause muscle atrophy, reduced function, inflammation, insulin resistance, cardiovascular issues, and unhealthy aging. Although IMAT results from fat accumulation in muscle, the mechanisms underlying its onset, development, cellular components, and functions remain unclear. IMAT levels are influenced by several factors, such as changes in the tissue environment, muscle type and origin, extent and duration of trauma, and persistent activation of fibro-adipogenic progenitors (FAPs). FAPs are a diverse and transcriptionally heterogeneous population of stromal cells essential for tissue maintenance, neuromuscular stability, and tissue regeneration. However, in cases of chronic inflammation and pathological conditions, FAPs expand and differentiate into adipocytes, resulting in the development of abnormal and ectopic IMAT. This review discusses the role of FAPs in adipogenesis and how they remodel IMAT. It highlights evidence supporting FAPs and FAP-derived adipocytes as constituents of IMAT, emphasizing their significance in adipose tissue maintenance and development, as well as their involvement in metabolic disorders, chronic pathologies and diseases. We also investigated the intricate molecular pathways and cell interactions governing FAP behavior, adipogenesis, and IMAT accumulation in chronic diseases and muscle deconditioning. Finally, we hypothesize that impaired cellular metabolic flexibility in dysfunctional muscles impacts FAPs, leading to IMAT. A deeper understanding of the biology of IMAT accumulation and the mechanisms regulating FAP behavior and fate are essential for the development of new therapeutic strategies for several debilitating conditions.

High dietary selenium intake is associated with less insulin resistance in the Newfoundland population

As an essential nutrient, Selenium (Se) is involved in many metabolic activities including mimicking insulin function. Data on Se in various biological samples and insulin resistance are contradictory, moreover there is no large study available regarding the relationship of dietary Se intake with insulin resistance in the general population. To investigate the association between dietary Se intake and variation of insulin resistance in a large population based study, a total of 2420 subjects without diabetes from the CODING (Complex Diseases in the Newfoundland Population: Environment and Genetics) study were assessed. Dietary Se intake was evaluated from the Willett Food Frequency questionnaire. Fasting blood samples were used for the measurement of glucose and insulin. Insulin resistance was determined with the homeostasis model assessment (HOMA-IR). Body composition was measured using dual energy X-ray absorptiometry. Analysis of covariance showed that high HOMA-IR groups in both males and females had the lowest dietary Se intake (μg/kg/day) (p < 0.01), being 18% and 11% lower than low HOMA-IR groups respectively. Insulin resistance decreased with the increase of dietary Se intake in females but not in males after controlling for age, total calorie intake, physical activity level, serum calcium, serum magnesium, and body fat percentage (p < 0.01). Partial correlation analysis showed that dietary Se intake was negatively correlated with HOMA-IR after adjusting for the Se confounding factors in subjects whose dietary Se intake was below 1.6 μg/kg/day (r = -0.121 for males and -0.153 for females, p < 0.05). However, the negative correlation was no longer significant when dietary Se intake was above 1.6 μg/kg/day. Our findings suggest that higher dietary Se intake is beneficially correlated with lower insulin resistance when total dietary Se intake was below 1.6 μg/kg/day. Above this cutoff, this beneficial effect disappears.

A 12-week aerobic exercise program without energy restriction improves intrahepatic fat, liver function and atherosclerosis-related factors

SUMMARY

OBJECTIVE

To study the effects of a 12-week continuous aerobic exercise program without energy restriction on intrahepatic fat, indices of liver function (aspartate aminotransferase [AST], alanine aminotransferase [ALT] and γ-glutamyl transpeptidase [γGTP]), plasminogen activator inhibitor-1 (PAI-1) and insulin resistance (HOMA-IR).

METHODS

Subjects were divided into two groups based on the degree of intrahepatic fat accumulation at baseline (high liver fat [HLF]: n = 13; low liver fat [LLF]: n = 14). Participants were instructed to exercise for more than 300 min per week at the lactate threshold. Fat accumulation (intramuscular, intrahepatic, visceral and subcutaneous fat) was evaluated by computed tomography. Blood samples were taken to determine the levels of AST, ALT, PAI-1, glucose and insulin.

RESULTS

Weight, body mass index, body fat, visceral fat and subcutaneous fat decreased significantly in both groups between baseline and post-intervention (P < 0.05), but were not significantly different between the two groups (P > 0.05). Intrahepatic fat, AST, ALT and PAI-1 improved significantly between baseline and post-intervention in the HLF group (P < 0.05; AST, P = 0.052), and improvements were significantly greater than those in the LLF group (P < 0.05). γGTP decreased significantly in the HLF group between baseline and post-intervention (P < 0.05), but was not significantly different between the two groups (P > 0.05). HOMA-IR did not significantly improve between baseline and post-intervention either within or between the two groups (P > 0.05).

CONCLUSION

This study revealed that a 12-week continuous aerobic exercise program without energy restriction might improve intrahepatic fat, liver function and atherosclerosis-related factors.